5.39
+1.25 (+30.19%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.69 | ||
| P/tB | N/A | ||
| EV/EBITDA | -4.95 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -92.83% | ||
| ROE | -99.27% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.73 | ||
| Quick Ratio | 3.73 | ||
| Altman-Z | -6.14 |
ChartMill assigns a fundamental rating of 2 / 10 to OHRP.
ChartMill assigns a valuation rating of 2 / 10 to Ohr Pharmaceutical Inc. (OHRP). This can be considered as Overvalued.
Ohr Pharmaceutical Inc. (OHRP) has a profitability rating of 1 / 10.
The dividend rating of Ohr Pharmaceutical Inc. (OHRP) is 0 / 10 and the dividend payout ratio is 0%.